We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.72B
AUM Growth
+$403M
Cap. Flow
+$53M
Cap. Flow %
0.93%
Top 10 Hldgs %
15.98%
Holding
769
New
66
Increased
305
Reduced
281
Closed
46

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$44.4M
2
PG icon
Procter & Gamble
PG
+$30.3M
3
BIDU icon
Baidu
BIDU
+$26.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$22.2M
5
LLY icon
Eli Lilly
LLY
+$22.1M

Sector Composition

Rank Sector Weight
1 Healthcare 27.14%
2 Technology 13.76%
3 Financials 13.55%
4 Consumer Discretionary 9.45%
5 Communication Services 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
S
326
DELISTED
Sprint Corporation
S
$3.58M 0.06%
460,458
+177,855
+63% +$1.46M
MAR icon
327
Marriott International
MAR
$98.7B
$3.56M 0.06%
32,337
-450
-1% -$46.4K
SYY icon
328
Sysco
SYY
$39.7B
$3.56M 0.06%
65,999
+3,645
+6% +$190K
SUPN icon
329
Supernus Pharmaceuticals
SUPN
$2.68B
$3.56M 0.06%
89,000
+18,000
+25% +$779K
OVV icon
330
Ovintiv
OVV
$17.5B
$3.54M 0.06%
60,238
-893
-1% -$43.6K
LH icon
331
Labcorp
LH
$24.3B
$3.53M 0.06%
27,242
-2,612
-9% -$348K
EGRX
332
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.52M 0.06%
59,000
+11,000
+23% +$665K
HST icon
333
Host Hotels & Resorts
HST
$16.8B
$3.49M 0.06%
188,761
-187,638
-50% -$3.41M
CALA
334
DELISTED
Calithera Biosciences, Inc
CALA
$3.46M 0.06%
11,000
-2,405
-18% -$759K
CSX icon
335
CSX Corp
CSX
$98.6B
$3.46M 0.06%
191,319
+3,351
+2% +$57.5K
EW icon
336
Edwards Lifesciences
EW
$47.6B
$3.44M 0.06%
94,521
+327
+0.3% +$12.5K
SCHW
337
Charles Schwab
SCHW
$177B
$3.39M 0.06%
77,596
+3,062
+4% +$127K
BCE icon
338
BCE
BCE
$19.9B
$3.39M 0.06%
72,519
+3,140
+5% +$147K
HPQ icon
339
HP
HPQ
$23.5B
$3.38M 0.06%
169,505
-15,585
-8% -$297K
SAGE
340
DELISTED
Sage Therapeutics
SAGE
$3.36M 0.06%
54,000
-9,000
-14% -$707K
LUMO
341
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$3.34M 0.06%
36,444
+28,111
+337% +$2.16M
BC icon
342
Brunswick
BC
$5.19B
$3.32M 0.06%
+59,355
New +$3.33M
BNS icon
343
Scotiabank
BNS
$106B
$3.32M 0.06%
51,788
-8,306
-14% -$516K
SO icon
344
Southern Company
SO
$110B
$3.31M 0.06%
67,451
+1,586
+2% +$76.9K
TFC icon
345
Truist Financial
TFC
$63.2B
$3.31M 0.06%
70,605
-606
-0.9% -$27.9K
D icon
346
Dominion Energy
D
$62.5B
$3.27M 0.06%
42,554
+1,512
+4% +$118K
ZTS icon
347
Zoetis
ZTS
$31.6B
$3.26M 0.06%
51,163
+3,943
+8% +$247K
WMT icon
348
Walmart Inc
WMT
$871B
$3.22M 0.06%
123,741
+16,872
+16% +$443K
CME icon
349
CME Group
CME
$92.2B
$3.22M 0.06%
23,717
+1,107
+5% +$140K
RIGL icon
350
Rigel Pharmaceuticals
RIGL
$680M
$3.21M 0.06%
126,500
+8,500
+7% +$207K

Similar funds

Candriam SCA's Q3 2017 Portfolio in Review

As of Q3 2017, Candriam SCA held 769 positions worth $5.72B, up 7.6% from $5.32B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q3 2017 filing shows 66 new, 305 increased, 281 reduced and 46 closed positions. Its largest new stake was Alaska Air: 139,079 shares worth $10.6M. The largest sale was GE Aerospace, an estimated $30.7M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2017 buy was Alaska Air: 139,079 shares worth $10.6M.
  • Candriam SCA added most to Microsoft in Q3 2017, an estimated $44.4M increase.
  • Candriam SCA's biggest Q3 2017 reduction was GE Aerospace, cutting an estimated $30.7M.
  • Candriam SCA fully exited Staples Inc in Q3 2017, selling an estimated $26.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.72B portfolio in Q3 2017.
  • Candriam SCA opened 66 new positions and closed 46 in Q3 2017.
  • Candriam SCA's portfolio value rose 7.6% quarter-over-quarter to $5.72B.

Based on Candriam SCA's 13F filing for Q3 2017, filed 3 Nov 2017.